Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Common Equity (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Common Equity for 6 consecutive years, with $143.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 7.67% year-over-year to $143.5 million, compared with a TTM value of $143.5 million through Dec 2025, up 7.67%, and an annual FY2025 reading of $143.5 million, up 7.67% over the prior year.
  • Common Equity was $143.5 million for Q4 2025 at Viemed Healthcare, up from $133.6 million in the prior quarter.
  • Across five years, Common Equity topped out at $143.5 million in Q4 2025 and bottomed at $83.4 million in Q1 2021.
  • Average Common Equity over 5 years is $110.7 million, with a median of $106.7 million recorded in 2023.
  • The sharpest move saw Common Equity surged 70.96% in 2021, then rose 2.4% in 2022.
  • Year by year, Common Equity stood at $94.8 million in 2021, then rose by 2.4% to $97.1 million in 2022, then increased by 17.3% to $113.9 million in 2023, then increased by 17.04% to $133.3 million in 2024, then grew by 7.67% to $143.5 million in 2025.
  • Business Quant data shows Common Equity for VMD at $143.5 million in Q4 2025, $133.6 million in Q3 2025, and $141.6 million in Q2 2025.